Biotech Values

[dav1234]

Mylan (MYL) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6B in cash. The acquisition significantly expands MYL's global injectables platform and will provide entry into new high-growth geographic markets. The acquisition is expected to close in Q4 of 2013 should be immediately accretive to earnings. Shares +1.8% AH

http://seekingalpha.com/news-article/5767401-mylan-to-acquire-agila-to-create-leading-global-injectables-platform